Minggan Li is a notable inventor based in Saint Paul, MN (US). He has made significant contributions to the field of biomarker detection through his innovative patent. His work exemplifies the intersection of technology and healthcare, showcasing the potential for advancements in medical diagnostics.

Latest Patents

Minggan Li holds a patent titled "System and method for sample preparation in GMR-based detection of biomarkers." This invention features a cartridge assembly that includes a sample processing card and a substrate attached to it. The card is designed with an injection port for receiving a test sample, at least one metering chamber, and a mixing material source for introducing mixing materials to the metering chamber. Fluid communication channels connect the injection port and the mixing material source to the metering chamber, along with at least one output port for delivering the test sample to a sensor, such as a GMR sensor. The substrate is equipped with a sensor for sensing analytes in the test sample, electrical contact portions for connection with a reader unit, and a memory chip. Additionally, the assembly includes a pneumatic interface that connects with an off-board pneumatic system, allowing for the application of pressurized fluid to move the test sample and mixing materials to the sensor.

Career Highlights

Minggan Li is currently employed at Zepto Life Technology, Inc., where he continues to develop innovative solutions in the field of biomarker detection. His work is instrumental in advancing the capabilities of diagnostic technologies.

Collaborations

Minggan has collaborated with several professionals in his field, including Chad Brian Rheault and Todd Michael Klein. These collaborations have contributed to the development and refinement of his innovative technologies.

Conclusion

Minggan Li's contributions to the field of biomarker detection through his patent demonstrate his commitment to innovation and advancement in medical technology. His work has the potential to significantly impact the way biomarkers are detected and analyzed, paving the way for improved diagnostic methods.